A phase 2 trial of azacitidine and gemtuzumab ozogamicin therapy in older patients with acute myeloid leukemia BLOOD Nand, S., Othus, M., Godwin, J. E., Willman, C. L., Norwood, T. H., Howard, D. S., Coutre, S. E., Erba, H. P., Appelbaum, F. R. 2013; 122 (20): 3432-3439

View details for DOI 10.1182/blood-2013-06-506592

View details for Web of Science ID 000327666500013